Cytokines in myocarditis and cardiomyopathies

Current Opinion in Cardiology

Volumn 11, Issue 3, 1996, Pages 302-309

  Matsumori, Akira ^a  

^a NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

HEART DILATATION; HEART MUSCLE CONTRACTILITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOCOMPETENT CELL; PRIORITY JOURNAL; REVIEW; VIRUS MYOCARDITIS;

ANIMALS; CARDIOMYOPATHY, DILATED; CARDIOTONIC AGENTS; CYTOKINES; HEART INJURIES; HEPATITIS C; HUMANS; MICE; MICE, MUTANT STRAINS; MYOCARDITIS; QUINOLINES;

EID: 0029884787     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199605000-00011     Document Type: Review

References (72)

1. Kawai C, Matsumori A, Fujiwara H: Myocarditis and dilated cardiomyopathy. Annu Rev Med 1987, 38:221-239.
2. Abelmann WH, Lorell BH: The challenge of cardiomyopathy. J Am Coll Cardiol 1989, 13:1219-1239.
3. Olinde KD, O'Connell JB: Inflammatory heart disease: pathogenesis, clinical manifestations, and treatment of myocarditis. Annu Rev Med 1994, 45:481-490.
4. Caforio ALP, Stewart JT, McKenna WJ: Idiopathic dilated cardiomyopathy. BMJ 1990, 300:890-891.
5. Johnson RA, Palacios I: Dilated cardiomyopathies of the adult [second of two parts]. N Engl J Med 1982, 307:1119-1126.
6. Matsumori A, Kawai C: An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus. Circulation 1982, 66:377-380.
7. Matsumori A: Animal models: pathological findings and therapeutic considerations. In Viral Infection of the Heart. Edited by Banatvala JE. London: Edward Arnold; 1993:110-137.
8. Kawano H, Kawai S, Nishijo T, Shirai T, Inagaki Y, Okada R: An autopsy case of hypertrophic cardiomyopathy with pathological findings suggesting chronic myocarditis. Jpn Heart J 1994, 35:95-105.
9. Kyu B, Matsumori A, Sato Y, Okada I, Chapman NM, Tracy S: Cardiac persistence of cardioviral RNA detected by the polymerase chain reaction in a murine model of dilated cardiomyopathy. Circulation 1992, 86:522-530.
10. Why HJF, Meany BT, Richardson PJ, Olsen EGJ, Bowles NE, Cunningham L, Freeke CA, Archard LC: Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1994, 89:2582-2589.
11. Giacca M, Severini GM, Mestroni L, Salvi A, Lardieri G, Falaschi A, Camerini F: Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994, 24:1033-1040.
12. Martin AB, Webber S, Fricker FJ, Jaffe R, Demmler G, Kearny D, Zhang Y-H, Bodurtha J, Gelb B, Ni J, Bricker JT, Towbin JA: Acute myocarditis: rapid diagnosis by PCR in children. Circulation 1994, 90:330-339.
13. Matsumori A, Matoba Y, Sasayama S: Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation 1995, 92:2519-2525. This is the first report demonstrating the importance of HCV infection in patients with dilated cardiomyopathy and myocarditis.
14. Aria KTN, Sallie R, Sangar D, Alexander GJM, Smith H, Byrne J, Portmann B, Eddleston ALWF, Williams R: Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization. J Clin Invest 1993, 91:2226-2234.
15. Griffin DE: Cytokines in viral infections. Virology 1994, 5:403-404.
16. Spriggs MK: Cytokine and cytokine receptor genes "captured" by viruses. Curr Opin Immunol 1994, 6:526-529.
17. Henke A, Mohr C, Sprenger H, Graebner C, Stelzner A, Nain M, Gemsa D: Coxsackievirus B3-induced production of tumor necrosis factor-α, IL-1β, and IL-6 in human monocytes. J Immunol 1992, 148:2270-2277.
18. Koziel M, Dudley D, Afdhal N, Grakoui A, Rice C, Choo Q-L, Houghton M, Walker D: HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus: identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 1995, 96:2311-2321.
19. Minutello MA, Pileri P, Unutmaz D, Censini S, Kuo G, Houghton M, Brunetto MR, Bonino F, Abrignani S: Compartmentalization of T lymphocytes to the site of diseases: intrahepatic CD4+ T cell specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993, 178:17-25.
20. Levine B, Kalman J, Mayer L, Fillit MM, Packer M: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990, 323:236-241.
21. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S: Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994, 72:561-566. The authors found increased levels of various cytokines in patients with acute myocarditis and cardiomyopathies.
22. Katz SD, Rao R, Berman JW, Schwarz M, Demopoulos L, Bijou B, LeJemtel TH: Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure: relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation 1994, 90:12-16.
23. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL: Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995, 92:1487-1493.
24. Latini R, Bianchi M, Correale E, Dinarello CA, Fantuzzi G, Fresco C, Maggioni AP, Mengozzi M, Romano S, Shapiro L, Sironi M, Rognoni G, Turato R, Ghezzi P: Cytokines In acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist J Cardiovasc Pharmacol 1994, 23:1-6.
25. Kapadia S, Torre-Amione G, Yokoyama T, Mann DL: Soluble TNF binding proteins modulate the negative inotropic properties of TNF-α in vitro. Am J Physiol 1995, 268:H517-H525.
26. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O: Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995, 92:1479-1486.
27. Packer M: Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation 1995, 92:1379-1382.
28. Limas CJ, Goldenberg IF, Limas C: Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy: correlation with disease severity and cardiac autoantibodies. Circulation 1995, 91:631-634.
29. Ikeda U, Ohkawa F, Seino Y, Yamamoto K, Hidaka Y, Kasahara Kawai T, Shimada K: Serum interleukin 6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol 1992, 24:579-584.
30. Ghezzi P, Dinarello CA, Bianchi M, Rosandich ME, Repine JE, While CW: Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine 1991, 3:189-194.
31. Yamauchi-Takihara K, Ihara Y, Ogata A, Yoshizaki K, Azuma J, Kishimoto T: Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 1995, 91:1520-1524.
32. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL: Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 1995, 96:1042-1052.
33. Tsujino M, Hirata Y, Imai T, Kanno K, Eguchi S, Ito H, Marumo F: Induction of nitric oxide synthase gene by interleukln-1β in cultured rat cardiocytes. Circulation 1994, 90:375-383.
34. Balligand J-L, Ungureanu D, Kelly RA, Pimentai D, Michel T, Smith TW: Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 1993, 91:2314-2319.
35. Evans HG, Lewis MJ, Shar AM: Interleukin-1β modulates myocardial contraction via dexamethasone-sensitive production of nitric oxide. Cardiovasc Res 1993, 27:1486-1490.
36. 2+]i and cell contraction in cultured chick ventricular myocytes. Circ Res 1994, 75:285-295.
37. Hosenpud JD, Campbell SM, Mendelson DJ: Interleukin-1 induced myocardial depression in an isolated beating heart preparation. J Heart Transplant 1989, 8:460-468.
38. Weisensee D, Bereiter-Hahn J, Schoeppe W, Friedrich LW: Effects of cytokines on the contractility of cultured cardiac myocytes. Int J Immunopharmacol 1993, 15:581-587.
39. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992, 257:387-389.
40. Li Y-H, Rozanski GJ: Effects of human recombinant interleukin-1 on electrical properties of guinea pig ventricular cells. Cardiovasc Res 1993, 27:525-530.
41. 2+ current by interleukin-1β in cultured rat ventricular myocytes. Am J Physiol 1995, 268:C339-C349.
42. Libby P, Warner SJ, Friedman GB: Interleukin 1 : a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoid. J Clin Invest 1988, 81:487-498.
43. Boluyt MO, O'Neill L, Meredith AL, Bing OHL, Brooks WW, Conrad CH, Crow MT, Lakatta EG: Alternation in cardiac gene expression during the transition from stable hypertrophy to heart failure: marked upregulation of genes encoding: extracellular matrix components. Circ Res 1994, 75:23-32.
44. Pinsky DJ, Cai B, Yang X, Rodriguez C, Sciacca RR, Cannon PJ: The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor β. J Clin Invest 1995, 95:677-685.
45. Woodley SL, McMillan M, Shelby J, Lynch DH, Roberts LK, Ensley RD, Barry WH: Myocyte injury and contraction abnormalities produced by cytotoxic T lymphocytes. Circulation 1991, 83:1410-1418.
46. Seko Y, Ishiyama S, Nishikawa T, Kasajima T, Hiroe M, Kagawa N, Osada K, Suzuki S, Yagita H, Okumura K, Yazaki Y: Restricted usage of T cell receptor Vα-Vβ genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy. J Clin Invest 1995, 96:1035-1041.
47. Thaik CM, Calderone A, Takahashi N, Colucci WS: Interleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest 1995, 96:1093-1099.
48. Beck AC, Ward JH, Hammond EH, Wray RB, Samlowski WE: Cardiomyopathy associated with high-dose Interleukln-2 (IL-2) therapy. West J Med 1991, 158:293-296.
49. Sobotka PA, McMannis J, Fisher RI, Stein DG, Thomas JX Jr.: Effects of interleukin 2 on cardiac function in the isolated rat heart J Clin Invest 1990, 86:845-850.
50. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL: Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart J Clin Invest 1993, 92:2303-2312.
51. Ungureanu-Longrois D, Balligand J-L, Simmons WW, Okada I, Kobzik L, Lowenstein CJ, Kunkel SL, Michel T, Kelly RA, Smith TW: Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to β-adrenergic agonists. Circ Res 1995, 77:494-502.
52. Balligand J-L, Ungureanu-Longrois D, Simmons WW, Pimentai D, Malinski TA, Kapturczak M, Taha Z, Lowenstein CJ, Davidoff AJ, Kelly RA, Smith TW, Michel T: Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem 1994, 269:27580-27588.
53. Shindo T, Ikeda U, Ohkawa F, Kawahara Y, Yokoyama M, Shimada K: Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines. Cardiovasc Res 1995, 29:813-819.
54. Ungureanu-Longrois D, Balligand J-L, Okada I, Simmons WW, Kobzik L, Lowenstein CJ, Kunkel SL, Michel T, Kelly RA, Smith TW: Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture. Circ Res 1995, 77:486-493.
55. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuck GD: The role of nitric oxide in cardiac depression induced by interleukin-1β and tumor necrosis factor-α. Br J Pharmacol 1995, 114:27-34.
56. Wei X-Q, Charles IG, Smith A, Ure J, Feng G-J, Huang F-P, Xu D, Muller W, Moncada S, Liew FY: Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995, 375:408-411. This report describes a new development of iNOS knockout mice. iNOS knockout mice were susceptible to protozoa infection but resistant to lipopolysaccharide. The results also suggested that iNOS may regulate Th1 cell function.
57. De Beider AJ, Radomski MW, Why HJF, Richardson PJ, Bucknall CA, Sales E, Martin J, Moncada S: Nitric oxide synthase activities in human myocardium [abstract]. Lancet 1993, 341:84-85.
58. Wang WZ, Okada I, Matsui S, Matsumori A: Comparative study of calcium channel blockers in a murine model of congestive heart failure induced by viral myocarditis: a possible mechanism though inhibition of nitric oxide production [abstract]. Circulation 1995, 92(suppl I):I-25.
59. Szabó C, Mitchell JA, Gross SS, Thiemermann C, Vane JR: Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide. J Pharmacol Exp Ther 1993, 265:674-680.
60. Dong R, Liu P, Wee L, Vutany J, Sole MJ: Verapamil ameliorates the clinical and pathological course of murine myocarditis. J Clin Invest 1993, 90:2022-2030.
61. Block LH, Keul R, Crabos M, Ziesche R, Roth M: Transcriptional activation of low density lipoprotein receptor gene by angiotensin-converting enzyme inhibitors and Ca(2+)-channel blockers involves protein kinase C isoforms. Proc Natl Acad Sci U S A 1993, 90:4097-4101.
62. Mahe Y, Wakasugi H, Scamps C, Chouaib S, Tursz T: Role of calcium on interleukin-1 production by monocytes: its relevance during T cell proliferation. Lymphokine Cytokine Res 1991, 10:165-172.
63. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 1992, 6:3051-3064.
64. Beckman JS: The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 1991, 15:53-59.
65. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA 1990, 87:1620-1624.
66. Matsumori A, Yamada T, Kawai C: Immunomodulating therapy in viral myocarditis: effects of tumor necrosis factor, Interleukin 2 and anti-interleukin-2 receptor antibody in an animal model. Eur Heart J 1991, 12(suppl D):203-205.
67. Yamada T, Matsumori A, Sasayama S: Therapeutic effects of anti-tumor necrosis factor-α antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 1994, 89:846-851.
68. Matsui S, Matsumori A, Matoba Y, Uchida A, Sasayama S: Treatment of virus-induced myocardial injury with a novel immunomodulating agent vesnarinone: suppression of natural killer cell activity and tumor necrosis factor-α production. J Clin Invest 1994, 94:1212-1217.
69. Shioi T, Matsumori A, Matsui S, Sasayama S: Inhibition of cytokine production by a new inotropic agent, vesnarinone, in human lymphocytes, T cell line, and monocytic cell line. Life Sci 1994, 54:PL11-16.
70. Matsumori A, Shioi T, Yamada T, Matsui S, Sasayama S: Vesnarinone, a new inotropic agent inhibits cytokine production by stimulated human blood from patients with heart failure. Circulation 1994, 89:955-958. This report demonstrates that an inotropic agent, which has been shown to improve survival of patients with heart failure, suppressed cytokine production in patients with heart failure.
71. Sato Y, Matsumori A, Sasayama S: Inotropic agent vesnarinone inhibits cytokine production and E-selectin expression in human umbilical vein endothelial cells. J Mol Cell Cardiol 1995, 27:2265-2273.
72. Matsui S, Matsumori A, Sasayama S: Vesnarinone prolongs survival and reduces lethality in a murine model of lethal endotoxemia. Life Sci 1994, 55:1735-1741.